Phospholipid nanodisc engineering for drug delivery systems

Area of Science:

• Biomaterials Science
• Nanotechnology
• Drug Delivery Systems

Background:

• Biocompatible mesoscale nanoparticles (5-100 nm) like liposomes and polymer micelles are used for drug delivery.
• Polyethylene glycol (PEG) coating enhances biocompatibility but can cause antigenicity and limit cellular uptake.
• Alternative nanocarriers are needed to overcome PEG limitations.

Purpose of the Study:

• To review the use of synthetic high-density lipoprotein (HDL)-like nanodiscs as biocompatible drug carriers.
• To focus on manufacturing, size-control, drug loading, and cell targeting of these nanodiscs.

Main Methods:

• Synthesis of HDL-like nanodiscs by mixing recombinant apoA-I proteins with phospholipids.
• Characterization of nanodisc properties including size and drug loading capacity.
• Evaluation of cell targeting capabilities.

Main Results:

• HDL-like nanodiscs can be synthesized in vitro with controlled size.
• These nanodiscs demonstrate potential for efficient drug loading.
• Engineered HDL-like nanodiscs show promise for targeted drug delivery.

Conclusions:

• Synthetic HDL-like nanodiscs represent a viable alternative to PEGylated nanoparticles.
• These nanodiscs offer improved biocompatibility and cellular uptake for drug delivery.
• Further research into manufacturing, drug loading, and targeting is warranted.